Novasep build new antibody drug conjugate facility in France

Novasep to build new antibody drug conjugate facility in France

1:43 PM, 25th June 2015
Novasep to build new antibody drug conjugate facility in France
Dr Michel Spagnol, chairman and CEO, Novasep. (File photo)

POMPEY, FRANCE: Novasep Holding SAS said it will build a fully integrated, new antibody drug conjugate (ADC) facility at its Le Mans site in France, complementing its current ADC offering with full bio-conjugation services to meet increasing market demand.

Novasep’s €10 million investment in clinical and commercial scale ADC conjugation is a natural extension to its existing CMO offering and leverages its unique purification technologies. Novasep’s new ADC facility design is now complete, it said.

The facility to be commissioned in second quarter of 2016, will provide contract manufacturing in batch sizes from a few milligrams to 600g to ADC drug developers during clinical trial and commercial development phases.

“Combining chemistry and biology is not a given. Novasep is one of the few CMOs able to produce both commercial scale ADCs payloads and monoclonal antibodies,” said Thierry Van Nieuwenhove, president, Novasep’s synthesis BU. “Customers are now searching for a simplified supply chain to produce their ADC and other bio-conjugate drug substances. By integrating our R&D, analytical and manufacturing services within a single unit, we can give customers flexibility, assurance of supply and continuity in supply chains,” he added.

“This move is part of our “Back to basics” strategy, forging Novasep’s re-focus on growing core businesses. We are proud to see our Le Mans site continuing its growth in one of the pharmaceutical industry’s most exciting development areas,” said Dr Michel Spagnol, chairman and CEO, Novasep.

© Worldofchemicals News

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


Axalta starts waterborne coatings unit in Germany

WUPPERTAL, GERMANY: Axalta Coating Systems said it has commissioned its new waterborne manufacturing facility in Wuppertal, Germany, nine months after ...

Read more
Giving atoms their marching orders

COLUMBIA, US: Chemistry professor Linda Shimizu oversees a series of crowd-pleasing chemistry demonstrations in middle and high schools throughout cen ...

Read more
Wacker changes executive board; appoints new CFO

MUNICH, GERMANY: Wacker Chemie AG said executive board member Dr Tobias Ohler (44) will takeover as chief financial officer on 1 Nov, replacing Dr Joa ...

Read more
Towards graphene biosensors

BERLIN, GERMANY: For the first time, a team of scientists has succeeded in precisely measuring and controlling the thickness of an organic compound th ...

Read more
Research points way to designing crack-resistant metals

TEMPE, US: A recent study into the interactions of metal alloys at the nanometer and atomic scales is likely to aid advances in preventing the failure ...

Read more
A Schulman names first R&D director for Asia Pacific region

AKRON, US: A Schulman Inc said it has appointed Tony Daponte as the company’s first research & development director masterbatch for the Asia ...

Read more